Neoadjuvant and adjuvant therapy for renal cell carcinoma: critique, current trials and future directions

The following articles discuss the use of neoadjuvant therapy (drug treatment given before surgery) and adjuvant therapy (drug treatment given after surgery) for renal cell carcinoma, including a summary of current clinical trials and future directions.

Read the neoadjuvant article in UroToday here

Read the adjuvant article in UroToday here

Share this Post!

Related post